SERBP1 and triple-negative breast carcinoma: In triple-negative breast cancer (TNBC), SERBP1 inhibits tumor progression by regulating alternative splicing of genes: SERBP1 interacts with the splicing factor SF3B1 to promote the exon 3 skipping splicing of the ME3 (Methylmalonyl-CoA Epimerase) gene.